This announcement is a separate document:
康美药业关于增加2024年度日常关联交易预计的公告
Announcement from Kangmei Pharmaceutical regarding the expected increase in routine related party transactions for the year 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.